AdvaMed® Statement on Today’s Violence at the U.S. Capitol
WASHINGTON, D.C. – On behalf of AdvaMed®, the world’s largest trade association representing medical technology companies, President and CEO Scott Whitaker released the following statement:
The Medtech Conference Wins Top Honors at IAEE 2020 Art of the Show Competition
Washington, D.C. — The Medtech Conference won several International Association of Exhibitions and Events (IAEE) Art of the Show Competition awards, including Best Email Promotion Campaign, Best Show Promotion Website, and tied for the prestigious…
AdvaMed® Praises U.S.-Ecuador Trade Package
The Advanced Medical Technology Association® (AdvaMed®) today issued the following statement from President and CEO Scott Whitaker on the newly concluded United States-Ecuador Trade Package announced today.
“Big Milestone”: Medtech Industry Has Shipped More Than 255 Million Molecular COVID-19 Tests Nationwide
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry shows that total U.S. shipments of COVID-19 molecular diagnostic tests have topped more than 255 million since the beginning of…
AdvaMed® Issues Medtech Industry Principles to Address Racial Health Disparities
Washington, D.C – Today the Advanced Medical Technology Association® (AdvaMed®), under the leadership of the Board of Directors, issued a set of principles to guide the industry in addressing racial health disparities.
AdvaMed® Welcomes Vision 2025 Roadmap to Reinforce Business Integrity Across APEC Region Amidst COVID-19
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) this week joined medtech industry, government and other health care stakeholders at the Asia-Pacific Economic Cooperation (APEC) Business Ethics for Small- and Medium-Sized…
AdvaMed® Announces 200 Million Molecular COVID-19 Tests Shipped Nationwide
WASHINGTON, D.C. –New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million. A breakdown of the data shows that…
AdvaMed® Announces 200 Million Molecular COVID-19 Tests Shipped Nationwide
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million. A breakdown of the data shows that…
AdvaMed® Praises “First-Ever” U.S.-Brazil Trade Package
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today issued the following statement from President and CEO Scott Whitaker on the newly concluded United States-Brazil Trade Package:
Weekly AdvaMed® COVID-19 Testing Registry Update: Over 190 Million Molecular Tests Shipped Nationwide
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached over 190 million. A breakdown of the data shows…